What this letter did not address is the fact that the US is hoarding almost all of Gilead's Remdesivir in the upcoming few months. Leaving the rest of the world with almost nothing.
It's fine. The formulation will get out there, and the world's chemists will figure out how to make it, and then the Indian generics factories will pump it out en masse.
The hard part with drugs is usually finding out if they work. This one is hard to make, but they'll figure it out.
And then each country gets to make the choice for itself of how much it loves IP law and how much it loves human life.
> In the developing world, where healthcare resources, infrastructure and economics are so different, we have entered into agreements with generic manufacturers to deliver treatment at a substantially lower cost.
I assume this means that:
1. Remdesvir is not that hard to manufacture.
2. Gilead will license the drug to 3rd party factories, so no need to manufacture them in the US.
I wonder if this will indirectly lead people to start thinking about whether socialized medical systems stifle innovation and make the systems reliant on innovative "capitalist" economies.
not sure if totally accurate but if it is then it serves the rest of the world right for playing nice with the US while the US screws them over anytime it is convenient
the rest of the world can do the same. stockpile their own products, e.g. ventilators, masks, etc. then everyone dies, cause you need all the parts for a full cure. anyway, it's more about the attitude of the US. I doubt stockpiling this drug has any consequence on the rest of the world. the just bought the first batches I guess. more will be produced.
Hopefully now that this is determined as effective the manufacturing can ramp up and the whole world can get access.